title: [Severe esophageal stenosis secondary to the administration of chemotherapy in a patient with acute myeloblastic leukemia].
authors.forename: M A
authors.initials: MA
authors.lastname: Canales Albendea
authors.forename: M T
authors.initials: MT
authors.lastname: Alvarez Román
authors.forename: R
authors.initials: R
authors.lastname: Villanueva Pavón
authors.forename: F
authors.initials: F
authors.lastname: Hernández Navarro
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002066:Busulfan / Q000009:adverse effects; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D004106:Dilatation; D004940:Esophageal Stenosis / Q000209:etiology*; D004941:Esophagitis / Q000139:chemically induced* / Q000150:complications / Q000628:therapy; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015479:Leukemia, Myelomonocytic, Acute / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction; D019172:Transplantation Conditioning / Q000009:adverse effects; D014456:Ulcer / Q000139:chemically induced* / Q000150:complications / Q000628:therapy
chemical_list: D000890:Anti-Infective Agents; D000897:Anti-Ulcer Agents; D003561:Cytarabine; D005047:Etoposide; D003520:Cyclophosphamide; D002066:Busulfan